retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide to Weight Loss, Appetite Control & Metabolic Reset Retatrutide—A Game Changer in Obesity

Novel diabetes drugs and the cardiovascular specialist

If youre changing between brand-name GLP-1s, GoodRx, a platform for medication savings, shares seven tips to help you switch safely and confidently

UK Adults Double Use of GLP-1 Weight-Loss Drugs The rapid rise of GLP-1 weight-loss drugs is beginning to alter consumer behaviour in the UK, with significant implications for the food, drink and hospitality sectors

Results were published in peer-reviewed journals and scrutinized by the global medical community

The glucose-dependent nature of tirzepatide's insulin secretion mechanism means that hypoglycemia risk remains relatively low when used as monotherapy, though caution is warranted when combined with insulin or sulfonylureas

3094 in the Eastern District of Pennsylvania has grown to include over 1,800 active cases, with plaintiffs continuing to join weekly